Hand-foot syndrome
MONDO:0700048A condition characterized by redness, pain, swelling, and tingling in the palms of the hands or the soles of the feet. It may appear as a side effect to chemotherapy agents.
Also known as: palmar-plantar erythrodysthesia
16 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Ice plant cream may shield cancer patients from chemo side effect
Prevention CompletedThis small pilot study tested whether an ice plant cream could prevent hand-foot syndrome (pain, redness, peeling on hands and feet) in 15 breast cancer patients receiving doxorubicin or docetaxel chemotherapy. The main goal was to see if a larger study is possible, not to prove …
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Can vitamin e cream soothe Chemo's painful skin side effect?
Symptom relief CompletedThis study tested whether adding a moisturizing cream with or without vitamin E (from palm oil) to a standard urea-based cream helps resolve hand-foot skin reactions caused by the chemotherapy drug capecitabine. 145 cancer patients with mild skin reactions took part. The goal was…
Phase: NA • Sponsor: Sarawak General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Simple gel may prevent chemo side effect
Symptom relief CompletedThis study looked at whether applying a topical diclofenac gel to the hands and feet could prevent or delay hand-foot syndrome in patients with colorectal or gastric cancer taking capecitabine. About 150 patients were observed at two cancer centers in Turkey. The goal was to see …
Sponsor: Gazi University • Aim: Symptom relief
Last updated Jun 26, 2026 18:33 UTC
-
Zinc and cream combo may stop painful side effect of cancer treatment
Symptom relief CompletedThis study tested whether taking zinc supplements and applying a strong steroid cream (clobetasol) can prevent or reduce hand-foot skin reaction, a common and painful side effect of the cancer drug regorafenib. About 150 patients starting regorafenib were split into three groups:…
Phase: NA • Sponsor: Gazi University • Aim: Symptom relief
Last updated Jun 26, 2026 17:04 UTC
-
AI could cut skin specialist wait times, study hints
Knowledge-focused CompletedThis study tested an artificial intelligence algorithm designed to help primary care doctors decide whether a patient with a skin condition really needs to see a dermatologist. Researchers enrolled 200 adults with skin problems and had their doctors take photos of the affected ar…
Sponsor: AI Labs Group S.L • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC